NCT00175955View on ClinicalTrials.gov

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

PHASE2CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Dyskinesia, Medication-induced

Interventions

DRUG

Levetiracetam

Trial Locations (7)

Unknown

Antwerp

Bourgois

Gonce

Hulselmans

Liège

Roeselare

Haralanov

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY